Home Home Home Inbox Home Search

Event

Eosinophilic Granulomatosis with Polyangiitis Patient Characteristics and Clinical Response to Mepolizumab Compared to Placebo [Board No. P644]

Location: Board no. P644
Session Type: Thematic Poster Session
Monday
May
21
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Michael E. Wechsler

MD, MMSc
National Jewish Health

Jonathan Steinfeld

MD
GSK Pharmaceuticals

Judith Brown

MS
GSK Pharmaceuticals

Eric Speir. Bradford

MD
GlaxoSmithKline;GSK

Stephen Mallett

MSc
GSK Pharmaceuticals

Steven W. Yancey

MBA, MS
GlaxoSmithKline;GSK

View Abstract

Eosinophilic Granulomatosis with Polyangiitis Patient Characteristics and Clinical Response to Mepolizumab Compared to Placebo

Parent Sessions

  • B32 - CLINICAL STUDIES IN AUTOIMMUNE LUNG DISEASE...
    05-21-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search